Merck KGaA
XHAM:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck KGaA
XHAM:MRK
|
DE |
|
A
|
Alpha Services and Holdings SA
SWB:ACBB
|
GR |
|
O
|
Old Dominion Freight Line Inc
SWB:ODF
|
US |
|
Basf Se
LSE:0BFA
|
DE |
|
Third Coast Bancshares Inc
NYSE:TCBX
|
US |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
|
U
|
United Tractors Tbk PT
XMUN:UTY
|
ID |
|
G
|
Guillemot Corporation SA
LSE:0NB2
|
FR |
|
Kering SA
PAR:KER
|
FR |
|
KeyCorp
NYSE:KEY
|
US |
|
Systemair AB
F:52SA
|
SE |
|
Aptose Biosciences Inc
OTC:APTOF
|
CA |
|
Mineral Resources Ltd
ASX:MIN
|
AU |
|
D
|
Dr Martens PLC
OTC:DRMTY
|
UK |
|
Fox Corp
NASDAQ:FOXA
|
US |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
H
|
Hexindo Adiperkasa Tbk PT
XMUN:HX1A
|
ID |
Bankruptcy Probability
Merck KGaA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Merck KGaA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Merck KGaA
XETRA:MRK
|
52.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
166.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
118.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Basf Se
XETRA:BAS
|
46.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
963.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
553.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
227.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Merck KGaA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Merck KGaA has total debt of 10.7B EUR. This includes both short-term (0 EUR) and long-term (10.7B EUR) debt.
You can find a full breakdown on its Balance Sheet.
